Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.

J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545. Epub 2008 Jan 21.

PMID:
18208910
2.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
4.

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.

Gouzoulis-Mayfrank E, Daumann J.

J Psychopharmacol. 2006 Mar;20(2):188-93. Review.

PMID:
16510477
5.
6.

The harmful health effects of recreational ecstasy: a systematic review of observational evidence.

Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.

Health Technol Assess. 2009 Jan;13(6):iii-iv, ix-xii, 1-315. doi: 10.3310/hta13050. Review.

7.

The neuropsychology of ecstasy (MDMA) use: a quantitative review.

Zakzanis KK, Campbell Z, Jovanovski D.

Hum Psychopharmacol. 2007 Oct;22(7):427-35. Review.

PMID:
17896346
8.

Drug-related decrease in neuropsychological functions of abstinent drug users.

van Holst RJ, Schilt T.

Curr Drug Abuse Rev. 2011 Mar;4(1):42-56. Review.

PMID:
21466500
9.

A review of the acute subjective effects of MDMA/ecstasy.

Baylen CA, Rosenberg H.

Addiction. 2006 Jul;101(7):933-47. Review.

PMID:
16771886
10.

Ecstasy (MDMA): a review of its possible persistent psychological effects.

Morgan MJ.

Psychopharmacology (Berl). 2000 Oct;152(3):230-48. Review.

PMID:
11105933
11.

The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.

Karlsen SN, Spigset O, Slørdal L.

Basic Clin Pharmacol Toxicol. 2008 Jan;102(1):15-24. Epub 2007 Nov 28. Review.

12.

Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.

Montoya AG, Sorrentino R, Lukas SE, Price BH.

Harv Rev Psychiatry. 2002 Jul-Aug;10(4):212-20. Review.

PMID:
12119307
13.

[Psychiatric and cognitive long-term effects of ecstasy].

Høiseth G, Løvåsdal Ø, Titze TK, Bramness JG, Bachs L.

Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):596-8. Review. Norwegian.

14.

Long term psychiatric and cognitive effects of MDMA use.

McGuire P.

Toxicol Lett. 2000 Mar 15;112-113:153-6. Review.

PMID:
10720725
15.
16.

Differential effects of ecstasy on short-term and working memory: a meta-analysis.

Nulsen CE, Fox AM, Hammond GR.

Neuropsychol Rev. 2010 Mar;20(1):21-32. doi: 10.1007/s11065-009-9124-z. Epub 2010 Feb 16. Review.

PMID:
20157852
17.

Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review.

Murphy PN, Wareing M, Fisk JE, Montgomery C.

Neuropsychobiology. 2009;60(3-4):159-75. doi: 10.1159/000253552. Epub 2009 Nov 5. Review.

PMID:
19893333
18.
19.

The health effects of ecstasy: a literature review.

Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL.

Drug Alcohol Rev. 2002 Mar;21(1):53-63. Review.

PMID:
12189005
20.

Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects.

Verbaten MN.

Curr Drug Abuse Rev. 2010 Sep;3(3):129-38. Review.

PMID:
21054259
Items per page

Supplemental Content

Write to the Help Desk